A Post-Market Assessment of the Safety and Performance of the TriClip™ System (TREAT TR)
Status: Recruiting
Location: See all (9) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject is eligible to receive the TriClip System per the current approved indications for use and is intended to undergo the procedure.
• Subject, or their legally authorized representative, has provided written informed consent prior to study procedure.
• Subject agrees to attend follow-up assessments.
• Subject is ≥ 18 years of age (or legal age of consent) at time of consent.
Locations
United States
Arizona
Banner University Medical Center Phoenix
RECRUITING
Phoenix
California
Scripps Health
RECRUITING
La Jolla
Illinois
Northwestern Memorial Hospital
RECRUITING
Chicago
Texas
Ascension Texas Cardiovascular Research
RECRUITING
Austin
Virginia
Sentara Norfolk General Hospital
RECRUITING
Norfolk
Other Locations
Germany
St. Johannes Hospital
RECRUITING
Dortmund
Italy
Ospedale San Raffaele - Cardiac
RECRUITING
Milan
Spain
Hospital Clínic de Barcelona
RECRUITING
Barcelona
Hospital Universitario Central de Asturias
RECRUITING
Oviedo
Contact Information
Primary
Allison Wood
allison.wood@abbott.com
612-518-9034
Backup
Jennifer Studt
jennifer.studt@abbott.com
314-616-2790
Time Frame
Start Date: 2026-07-02
Estimated Completion Date: 2033-08
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Abbott Medical Devices